Vnitr Lek 2007, 53(3):242-245

Cognitive dysfunction in patients with systemic lupus erythemathosus with or without antiphospholipid antibodies

Ľ. Cibičková1,*, T. Soukup1, E. Čermáková2, P. Bradna1, Z. Hrnčíř1
1 II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.
2 Ústav lékařské biofyziky Lékařské fakulty UK Hradec Králové, přednosta doc. Ing. Josef Hanuš, CSc.

Introduciton:
Impairment of cognitive functions is one of the neuropsychiatric symptoms of systemic lupus erythemathosus (SLE), the association of which with secondary antiphospholipid syndrome is often mentioned in the literature on the subject. Ethiology has not yet been fully clarified.

Patients and methods:
The aim of the study was to compare the "mini-mental state examination" (MMSE) outcomes in SLE patients with and without antiphospholipid antibodies (APA).

Results:
Probands producing APA presented with significantly worse results in MMSE when compared to patients without these antibodies. There was no difference between patients with antisphospholipid syndrome and those with APA only.


Discussion and conclusion:
Our study supports the notion that association of SLE with APA (not only with antiphospholipid syndrome) aggravates the deterioration of cognitive functions. MMSE test should not be omitted in the follow-up of SLE patients.

Keywords: systemic lupus erythematosus; antiphospholipid antibodies; cognitive functions; mini-mental state examination

Received: October 23, 2006; Accepted: January 2, 2007; Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibičková Ľ, Soukup T, Čermáková E, Bradna P, Hrnčíř Z. Cognitive dysfunction in patients with systemic lupus erythemathosus with or without antiphospholipid antibodies. Vnitr Lek. 2007;53(3):242-245.
Download citation

References

  1. Hochberg M Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1734.
  2. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311. Go to original source...
  3. Asherson RA, Mercey D, Philips G et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987; 46: 605-611. Go to original source... Go to PubMed...
  4. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
  5. Asherson RA, Khamashta MA, Gil A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391-399. Go to original source... Go to PubMed...
  6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 11: 1271-1277. Go to original source... Go to PubMed...
  7. Folstein MF, Folstein SE, McHugn PR "Mini-Mental State": a practical Metod for grading the cognitive state of patients for the clinican. J Psychiatr Res 1975; 12: 189-198. Go to original source... Go to PubMed...
  8. Anthony JC, LeResche L, Niaz U et al. Limits of the "Mini-Mental State" as a screening test for dementia a and delirium among hospital patients. Psychol Med 1982; 12: 397-408. Go to original source... Go to PubMed...
  9. Peterová V, Faber J, Dostál C et al. EEG nálezy u nemocných se systémovým lupus erythematosus. Sborník lékařský 1999; 4: 309-313.
  10. Lee SI, Jeon HS, Yoo WH. Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction. Rheumatol Int 2004; 24: 305-308. Go to original source... Go to PubMed...
  11. Jirák R, Koukolník F. Demence - Neurobiologie, klinický obraz, terapie. 1. ed. Praha: Galén 2004: 85.
  12. Sastre-Garriga J, Montalban Y. APS and the brain. Lupus 2003; 12: 877-882. Go to original source... Go to PubMed...
  13. Harris EN, Gharavi AE, Asherson RA et al. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47-51. Go to PubMed...
  14. Maeshima E, Yamada Y, Yukawa S et al. Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus. Intern Med 1992; 31: 1169-1174. Go to original source... Go to PubMed...
  15. Asherson RA, Lubbe WF. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol 1988; 15: 539-543. Go to PubMed...
  16. Soltesz P, Veres K, Lakos G et al. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospektive study of 637 patients. Lupus 2003; 12: 302-307. Go to original source... Go to PubMed...
  17. Caronti B, Calderaro C, Alessandri C et al. Serum anti-β2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 1998; 11: 425-429. Go to original source... Go to PubMed...
  18. Chapman J, Cohen-Armon M, Schoenfeld Y et al. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127-133. Go to original source... Go to PubMed...
  19. Chapman J, Abu-Katash M, Inzelbarg R et al. Prevalence and clinical features of dementia associated with the antifosfolipid syndrome and circulating anticoagulants. J Neurol Sci 2002; 203-204: 81-84. Go to original source... Go to PubMed...
  20. Fukui T, Kawamura M, Hasegawa Y et al. Multiple cognitive impairments associated with systemic lupus erythematosus and antiphospholipid antibody syndrome: a form of progressive vascular dementia? European Neurology 2000; 43: 115-116. Go to original source... Go to PubMed...
  21. Brey RL, Holliday RL, Sakland AR et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002; 58: 1214-1220. Go to original source... Go to PubMed...
  22. Glanz BI, Schur PH, Lew RA et al. Lateralized cognitive dysfunction in patients with systemic lupus erythematosus. Lupus 2005; 14: 896-902. Go to original source... Go to PubMed...
  23. Erkan D, Yazici Y, Sobel R et al. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000; 27: 2817-2821. Go to PubMed...
  24. Mosek A, Yust I, Treves TA et al. Dementia and antiphospholipid antibodies. Dement Geriat Cogn Dis 2000; 11: 36-38. Go to original source... Go to PubMed...
  25. Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer's disease. Neuroepidemiology 2004; 23: 94-98. Go to original source... Go to PubMed...
  26. Rockwood K, Kirkland S, Hogan DB et al. Use of lipid-lowering agents, indication bias, and the risk of dementi in community-dwelling elderly people. Arch Neurol 2002; 59: 223-227. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.